Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06821568 · ClinicalTrials.gov registry record · NA
Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome
A NA study of Cognition and Alzheimer Disease and Related Dementias, sponsored by Hebrew SeniorLife.
- Recruiting
- Registry status
- NA
- Development phase
- 128
- Enrollment target
- 2
- Study locations
NCT06821568: Recruiting NA study of Cognition and Alzheimer Disease and Related Dementias, sponsored by Hebrew SeniorLife.
NCT06821568 is a NA study of Cognition and Alzheimer Disease and Related Dementias that is actively recruiting participants, run by Hebrew SeniorLife. The registered enrollment target is 128 participants, below the 168-participant average among 35 other Cognition trials with a reported enrollment target (24% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06821568, a NA study of Cognition and Alzheimer Disease and Related Dementias, is actively recruiting participants, sponsored by Hebrew SeniorLife.
- RECRUITING
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
- 2
- Study locations
Study Summary
The objective of this study is to determine the effects of a 6-month, home-based personalized transcranial direct current stimulation (tDCS) intervention targeting the left dorsolateral prefrontal cortex on cognitive function, dual task standing and walking, and other metrics of mobility in older adults with motoric cognitive risk syndrome (MCR).
Primary Outcome
This metric assesses the degree to which performing a secondary cognitive task diminishes the control of gait.
Conditions Studied
Interventions
- OTHER Personalized Transcranial Direct Current Stimulation (tDCS)
- OTHER Active-Sham
Study Locations (2)
Massachusetts
- Hebrew Rehabilitation Center - Roslindale
Other
- Tel Aviv Sourasky Medical Center - Tel Aviv
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2025-09-02 |
| Est. Completion | 2029-06 |
| Phase | NA |
What NCT06821568 shows while recruiting
NCT06821568 is an interventional study that assigns participants to a tested intervention. The registered 128 participants enrollment target is mid-sized for trials with a published cap, below the 168-participant average among 35 other Cognition trials with a reported enrollment target (24% lower).
The record links to 3 conditions, with Cognition appearing as the primary indexed condition, and to 2 interventions - of which Personalized Transcranial Direct Current Stimulation (tDCS) is the first listed.
NCT06821568 reports a single indexed study location in Massachusetts, Other.
Frequently Asked Questions
What is clinical trial NCT06821568 about?
NCT06821568 is a clinical study titled "Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome". The objective of this study is to determine the effects of a 6-month, home-based personalized transcranial direct current stimulation (tDCS) intervention targeting the left dorsolateral prefrontal cortex on cognitive function, dual task standing and walking, and other metrics of mobility in older ad...
What is the current status of trial NCT06821568?
This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2025-09-02. Estimated completion is 2029-06.
What conditions does trial NCT06821568 study?
This clinical trial studies the following conditions: Cognition, Alzheimer Disease and Related Dementias, Mobility Disability.
What interventions are being tested in trial NCT06821568?
The interventions under investigation include: Personalized Transcranial Direct Current Stimulation (tDCS) (OTHER), Active-Sham (OTHER).
Who is sponsoring clinical trial NCT06821568?
This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06821568 being conducted?
This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06821568's enrollment target sits among peer trials
128 8th of 35 higher than 28 of 35 other Cognition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cognition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Effect of Near-infrared Light Therapy on Brain Function and Cognition in Young and Older Adults
RECRUITING · NA
-
Nutrition to Support Postoperative Recovery
RECRUITING · NA
-
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
RECRUITING · NA
-
Identifying the Neural Correlates of Mental Simulation in Multi-Step Planning
RECRUITING · NA
-
Sleep Well Firefighters: An App-based Program to Improve Sleep, Cognition, and Behavioral Health in Firefighters
RECRUITING · NA
-
Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02870738 · 128 participants · Phase 2
Bladder Directed vs. Pelvic Floor Therapy in IC/BPS
- NCT03294460 · 128 participants · Phase 1
Nicotinic Receptor Genetic Variation and Alcohol Reward
- NCT04149977 · 128 participants · NA
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
- NCT04373057 · 128 participants · Phase 1
Prebiotic Galacto-oligosaccharide and Acute GVHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI